Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14619473rdf:typepubmed:Citationlld:pubmed
pubmed-article:14619473lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:14619473lifeskim:mentionsumls-concept:C0221464lld:lifeskim
pubmed-article:14619473lifeskim:mentionsumls-concept:C0494165lld:lifeskim
pubmed-article:14619473lifeskim:mentionsumls-concept:C0547070lld:lifeskim
pubmed-article:14619473lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:14619473lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:14619473lifeskim:mentionsumls-concept:C0850292lld:lifeskim
pubmed-article:14619473lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:14619473lifeskim:mentionsumls-concept:C1512948lld:lifeskim
pubmed-article:14619473pubmed:issue11lld:pubmed
pubmed-article:14619473pubmed:dateCreated2003-11-17lld:pubmed
pubmed-article:14619473pubmed:abstractTextWe performed radiofrequency ablation (RFA) therapy combined with intrahepatic arterial infusion chemotherapy for 7 patients with liver metastasis from colorectal cancer. Synchronous metastasis accounted for 5 cases and metachronous for 2 cases. Two cases were H1, 2 cases H2, and 3 cases H3. Following the resection of colorectal primary lesion, we performed RFA for liver metastasis, using a Cool-tip electrode purchased from Radionics (Burlington, MA, USA). The mean number of sessions per patient was 5.1 (1-10). Ablation time of each session was changed according to tumor size, as follows: less than 1 cm in diameter: 2 min, 2 cm: 5 min, 2.5 cm: 10 min. By using intra-operative catheterization, weekly intrahepatic arterial infusion chemotherapy was performed for liver metastasis. Excellent ablation was achieved in all cases by CT evaluation and no significant side-effect was observed. Average observation period was 15 months (maximal survival period was 31 months) and 6 patients are alive. RFA therapy combined with intrahepatic arterial infusion chemotherapy achieved excellent therapeutic effect, and maintained good quality of life in patients.lld:pubmed
pubmed-article:14619473pubmed:languagejpnlld:pubmed
pubmed-article:14619473pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14619473pubmed:citationSubsetIMlld:pubmed
pubmed-article:14619473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14619473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14619473pubmed:statusMEDLINElld:pubmed
pubmed-article:14619473pubmed:monthOctlld:pubmed
pubmed-article:14619473pubmed:issn0385-0684lld:pubmed
pubmed-article:14619473pubmed:authorpubmed-author:TakahashiMasa...lld:pubmed
pubmed-article:14619473pubmed:authorpubmed-author:InagakiMasaru...lld:pubmed
pubmed-article:14619473pubmed:authorpubmed-author:MiyoshiKazuya...lld:pubmed
pubmed-article:14619473pubmed:authorpubmed-author:OtsukaShinyaSlld:pubmed
pubmed-article:14619473pubmed:authorpubmed-author:OosakiToshihi...lld:pubmed
pubmed-article:14619473pubmed:authorpubmed-author:FuchimotoSada...lld:pubmed
pubmed-article:14619473pubmed:authorpubmed-author:SakataTatsuhi...lld:pubmed
pubmed-article:14619473pubmed:issnTypePrintlld:pubmed
pubmed-article:14619473pubmed:volume30lld:pubmed
pubmed-article:14619473pubmed:ownerNLMlld:pubmed
pubmed-article:14619473pubmed:authorsCompleteYlld:pubmed
pubmed-article:14619473pubmed:pagination1598-601lld:pubmed
pubmed-article:14619473pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:meshHeadingpubmed-meshheading:14619473...lld:pubmed
pubmed-article:14619473pubmed:year2003lld:pubmed
pubmed-article:14619473pubmed:articleTitle[Radiofrequency ablation therapy combined with intrahepatic arterial infusion chemotherapy for liver metastasis of colorectal cancer].lld:pubmed
pubmed-article:14619473pubmed:affiliationDept. of Surgery, Fukuyama National Hospital.lld:pubmed
pubmed-article:14619473pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14619473pubmed:publicationTypeEnglish Abstractlld:pubmed